In a short period of time, TransCelerate has achieved unprecedented progress, delivering tangible impact to benefit the broader biopharmaceutical industry. All this would not have been achievable without the active engagement and sponsorship from some of the most senior leaders in the industry.
In just a few years, our leaders have made significant strides toward our goal of making clinical development more efficient. TransCelerate leadership has an unwavering dedication to assessing, refining and creating processes to make the drug development environment efficient, safe and innovative.
Board of Directors
CEO, TransCelerate BioPharma Inc.
Chair of the Board, SVP, Global Development, Amgen
Vice Chair of the Board, EVP and Chief R&D Officer, Allergan
SVP, Global Clinical Development, Merck Research Laboratories
EVP, Global Medicines Development, and Chief Medical Officer, AstraZeneca Pharmaceuticals
EVP, Chief Development Officer, Pfizer Inc.
Vice President, Clinical Development Organization, Eli Lilly and Company
Head of Global Clinical Operations (GCO), Bristol-Myers Squibb
President, Global Research & Development, Sanofi
SVP, Global Head of Pharma Regulatory and Policy, Roche
Director, EVP, Shionogi & Co., Ltd.
Head, Global Development Operations, Novartis
Vice Chair of the Executive Committee and Chief Scientific Officer
Chief Medical Officer and President, Development, Astellas Pharma